Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

5.8K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
5.8K
Viral Recombination00:57

Viral Recombination

23.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.1K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

2.7K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
2.7K
Retroviruses02:33

Retroviruses

12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
What are Viruses?00:50

What are Viruses?

112.3K
Overview
112.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humanized mice enable <i>in vivo</i> evaluation of engineered plasma cell biology and therapeutic function.

Molecular therapy. Advances·2026
Same author

Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.

Cell reports. Medicine·2026
Same author

Isolation and characterization of broadly-neutralizing anti-HCMV-gB antibodies from human donors using a prefusion-stabilized HCMV gB variant.

PLoS pathogens·2026
Same author

Monoclonal neutralizing antibodies elicited by infection with Kaposi sarcoma-associated herpesvirus reveal critical sites of vulnerability on gH/gL.

PLoS pathogens·2026
Same author

Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks.

Nature genetics·2025
Same author

Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function.

bioRxiv : the preprint server for biology·2025
Same journal

Resolution Failure in Periodontal Diseases: Dysregulated Pro-resolving Mechanisms in Chronic Inflammation and Tissue Breakdown.

Current topics in microbiology and immunology·2026
Same journal

Correction to: Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
See all related articles

Related Experiment Video

Updated: May 15, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.1K

Viral Entry.

Samantha Hardy1, Crystal B Chhan1,2, Amelia R Davis1

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Current Topics in Microbiology and Immunology
|May 14, 2025
PubMed
Summary
This summary is machine-generated.

Epstein-Barr virus uses specific glycoproteins to infect human cells, primarily B cells and epithelial cells. Understanding these viral proteins and their receptor interactions is key to explaining viral entry mechanisms.

Keywords:
Epstein-Barr virusGlycoproteinViral entry

More Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.8K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

7.8K

Related Experiment Videos

Last Updated: May 15, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.1K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.8K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

7.8K

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) primarily infects B cells and epithelial cells.
  • Viral entry into host cells is a complex process.
  • Viral glycoproteins play a crucial role in determining tropism and mediating membrane fusion.

Purpose of the Study:

  • To review the function of Epstein-Barr virus glycoproteins in host cell entry.
  • To explore interactions between viral glycoproteins and host cell receptors.
  • To identify knowledge gaps in the EBV entry process.

Main Methods:

  • Literature review of existing research on EBV glycoproteins.
  • Analysis of studies detailing viral-host receptor interactions.
  • Identification of current limitations and future research directions in EBV entry mechanisms.

Main Results:

  • EBV glycoproteins are essential for mediating host cell entry.
  • Specific interactions between viral glycoproteins and host receptors dictate tropism.
  • Significant gaps remain in fully understanding the EBV entry pathway.

Conclusions:

  • A comprehensive understanding of EBV glycoprotein function is critical for elucidating viral pathogenesis.
  • Further research into viral-host interactions is needed to fill knowledge gaps.
  • Targeting viral entry mechanisms may offer therapeutic strategies.